addbio top3

About us

AddBIO was founded in 2008 and has developed a solution to solve the real problem in the implant industry-weak bone. By coating any implant on the market with a bioactive nanolayer with a bone –strengthening drug, we know that millions of patients will experience better results and faster recovery.

We call our product Zolidd®.

Zolidd® has been evaluated in both pre-clinical and clinical studies, in both instances with excellent results. The landmark clinical results in the dental indication have generated serious interest from major companies. Clinical results showing significant benefits in orthopaedic indications will be of equal importance in discussions with leading orthopaedic implant partners who can benefit from differentiation and clinical development.

ADDBIO

Ulf Sewerin
Ulf Sewerin
CEO
Mobile: +46 708 79 79 88
This email address is being protected from spambots. You need JavaScript enabled to view it.
Lotta Tolstoy Tegler

Lotta Tolstoy Tegler
CTO

Emelie Wänqvist

Emelie Wänqvist
R&D engineer

Amelié Wallenhammar

Amelié Wallenhammar
R&D engineer

BOARD

Henrik Rammer

Henrik Rammer

Chairman

Peter Selley

Peter Selley

Board member

Gunilla Lundmark

Gunilla Lundmark

Board member

Maarten de Château

Maarten de Château

Board member

ADVISORS

Christer Dahlin
Christer Dahlin
PhD, professor
Per Aspenberg
Per Aspenberg
PhD, professor
Anders Jönsson
Anders Jönsson
PhD
Pär-Olov Östman
Pär-Olov Östman
PhD, professor
Pentti Tengvall
Pentti Tengvall
PhD, professor